What is the Amrutanjan Health Care Ltd share price today?

The share price of NSE:AMRUTANJAN-EQ on 07 Sep 2026 (as of 10:58:47 IST) is ₹499.75.

What is the NSE:AMRUTANJAN-EQ 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:AMRUTANJAN-EQ 52 week high low range shows a high of ₹790.95 and a low of ₹482.80.

What is the Amrutanjan Health Care Ltd market cap?

As on 07 Sep 2026, Amrutanjan Health Care Ltd market cap is ₹1463.60 Cr.

What is the shareholding pattern of Amrutanjan Health Care Ltd Stock?

The shareholding pattern of Amrutanjan Health Care Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 46.52% Foreign Institutional Investors (FII): 2.44% Domestic Institutional Investors (DII): 6.47% Mutual Funds: 5.82% Retail & Others: 38.75% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Amrutanjan Health Care Ltd?

The Price-to-Earnings (PE) ratio of Amrutanjan Health Care Ltd is 27.12, and the Price-to-Book (PB) ratio is 5.72, as on 07 Sep 2026.

Amrutanjan Health Care Share Price

496.05+2.25 (+0.46%)

-35.16% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+0.46%

1 Week

+1.15%

1 Month

-7.51%

3 Month

-10.46%

6 Month

-4.46%

YTD

-25.80%

1 Year

-35.16%

5 Year

-35.82%

10 Year

+130.43%

Max

+1040.48%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

490.00

488.05

476.50

High

497.00

539.70

567.40

598.00

772.00

About

Amrutanjan Health Care Ltd is engaged in the manufacture of a wide range of ayurvedic and allopathic products. The company's products are available in the Gulf African South East and Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

AUROPHARMANSE

LUPINNSE

DRREDDYNSE

MANKINDNSE

AMRUTANJANNSE

LTP

1W Low

1W High

Market cap (₹)

1868.9+15.4 (0.83%)

1832.20

1891.50

4,40,398Cr

9410.5+252.5 (2.76%)

9135.50

9461.50

2,48,664Cr

4970+157.5 (3.27%)

4794.50

4986.50

1,82,738Cr

1161+53.5 (4.83%)

1100.10

1173.50

1,15,012Cr

1386.1+28.1 (2.07%)

1351.60

1405.20

1,10,794Cr

2017.5+112 (5.88%)

1894.80

2023.50

1,05,645Cr

1713.4+70.4 (4.28%)

1634

1738.90

99,828Cr

2124.5+79.5 (3.89%)

2046.30

2129

98,070Cr

1198.3+58.3 (5.11%)

1140

1211.90

97,749Cr

2437.8+191.8 (8.54%)

2242.10

2452

95,744Cr

496.95+6.55 (1.34%)

488.05

497

1,427Cr

Amrutanjan Health Care Share Price

496.05+2.25 (+0.46%)

-35.16% past 1 Year

Financial overview

Compounded Sales Growth

10 years11%

5 years9%

3 years10%

Last year11%

Compounded Profit Growth

10 years10%

5 years-1%

3 years13%

Last year14%

Stock Price CAGR

10 years9%

5 years-9%

3 years-8%

1 year-35%

Return on Equity

10 years19%

5 years18%

3 years16%

Last year17%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
11%	9%	10%	11%
10%	-1%	13%	14%
9%	-9%	-8%	-35%
19%	18%	16%	17%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

AUROPHARMA

LUPIN

DRREDDY

MANKIND

AMRUTANJAN

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,868.9	₹440398 Cr	36.41	12.07	62.82	₹11479 Cr
9,410.5	₹248664 Cr	85.01	34.04	128.41	₹2568 Cr
4,970	₹182738 Cr	83.79	16.72	97.06	₹2163 Cr
1,161	₹115012 Cr	25.48	9.42	62.53	₹5040 Cr
1,386.1	₹110794 Cr	32.87	9.77	57.87	₹3879 Cr
2,017.5	₹105645 Cr	96.62	6.8	29.25	₹889 Cr
1,713.4	₹99828 Cr	26.89	17.95	96.84	₹3505 Cr
2,124.5	₹98070 Cr	17.74	30.95	154.36	₹5333 Cr
1,198.3	₹97749 Cr	30.34	5.32	63.99	₹4196 Cr
2,437.8	₹95744 Cr	46.87	13.75	71.08	₹1913 Cr
496.95	₹1427 Cr	26.44	1.51	20.99	₹58 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2017	Dec 2016	Sep 2016	Jun 2016	Mar 2016	Dec 2015	Sep 2015	Jun 2015	Mar 2015	Dec 2014	Sep 2014	Jun 2014	Mar 2014	Dec 2013	Sep 2013	Jun 2013	Mar 2013	Dec 2012	Sep 2012
₹103 Cr	₹150 Cr	₹141 Cr	₹118 Cr	₹94 Cr	₹135 Cr	₹123 Cr	₹110 Cr	₹84 Cr	₹127 Cr	₹117 Cr	₹99 Cr	₹78 Cr	₹100 Cr	₹98 Cr	₹111 Cr	₹71 Cr	₹107 Cr	₹111 Cr	₹110 Cr	₹78 Cr	₹94 Cr	₹100 Cr	₹92 Cr	₹47 Cr	₹59 Cr	₹83 Cr	₹75 Cr	₹45 Cr	₹86 Cr	₹70 Cr	₹62 Cr	₹36 Cr	₹73 Cr	₹63 Cr	₹56 Cr	₹32 Cr	₹70 Cr	₹59 Cr	₹56 Cr	₹34 Cr	₹59 Cr	₹54 Cr	₹45 Cr	₹29 Cr	₹49 Cr	₹48 Cr	₹41 Cr	₹26 Cr	₹42 Cr	₹41 Cr	₹33 Cr	₹22 Cr	₹44 Cr	₹39 Cr	₹32 Cr
₹4 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹5 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹57 L	₹2 Cr	₹2 Cr	₹1 Cr	₹93 L	₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹97 L	₹1 Cr	₹94 L	₹37 L	₹82 L	₹90 L	₹75 L	₹1 Cr	₹97 L	₹1 Cr
₹107 Cr	₹154 Cr	₹145 Cr	₹122 Cr	₹98 Cr	₹140 Cr	₹127 Cr	₹114 Cr	₹88 Cr	₹132 Cr	₹121 Cr	₹103 Cr	₹82 Cr	₹105 Cr	₹101 Cr	₹114 Cr	₹74 Cr	₹112 Cr	₹114 Cr	₹115 Cr	₹81 Cr	₹97 Cr	₹103 Cr	₹96 Cr	₹49 Cr	₹62 Cr	₹85 Cr	₹77 Cr	₹46 Cr	₹89 Cr	₹72 Cr	₹64 Cr	₹37 Cr	₹74 Cr	₹65 Cr	₹58 Cr	₹33 Cr	₹70 Cr	₹60 Cr	₹57 Cr	₹35 Cr	₹61 Cr	₹55 Cr	₹47 Cr	₹30 Cr	₹50 Cr	₹49 Cr	₹42 Cr	₹27 Cr	₹43 Cr	₹42 Cr	₹34 Cr	₹23 Cr	₹46 Cr	₹40 Cr	₹33 Cr
₹99 Cr	₹126 Cr	₹117 Cr	₹103 Cr	₹87 Cr	₹119 Cr	₹101 Cr	₹98 Cr	₹82 Cr	₹112 Cr	₹97 Cr	₹94 Cr	₹72 Cr	₹89 Cr	₹87 Cr	₹96 Cr	₹69 Cr	₹91 Cr	₹86 Cr	₹88 Cr	₹65 Cr	₹83 Cr	₹74 Cr	₹65 Cr	₹40 Cr	₹51 Cr	₹72 Cr	₹64 Cr	₹47 Cr	₹68 Cr	₹64 Cr	₹54 Cr	₹39 Cr	₹63 Cr	₹57 Cr	₹43 Cr	₹34 Cr	₹63 Cr	₹51 Cr	₹46 Cr	₹32 Cr	₹51 Cr	₹43 Cr	₹36 Cr	₹28 Cr	₹41 Cr	₹39 Cr	₹35 Cr	₹26 Cr	₹33 Cr	₹34 Cr	₹30 Cr	₹22 Cr	₹35 Cr	₹35 Cr	₹29 Cr
₹10 Cr	₹30 Cr	₹29 Cr	₹21 Cr	₹13 Cr	₹23 Cr	₹28 Cr	₹18 Cr	₹8 Cr	₹21 Cr	₹25 Cr	₹11 Cr	₹11 Cr	₹18 Cr	₹16 Cr	₹19 Cr	₹6 Cr	₹22 Cr	₹29 Cr	₹27 Cr	₹17 Cr	₹15 Cr	₹29 Cr	₹32 Cr	₹10 Cr	₹12 Cr	₹14 Cr	₹13 Cr	-₹30,000	₹21 Cr	₹8 Cr	₹10 Cr	-₹1 Cr	₹11 Cr	₹9 Cr	₹15 Cr	-₹90 L	₹8 Cr	₹10 Cr	₹12 Cr	₹4 Cr	₹10 Cr	₹12 Cr	₹11 Cr	₹3 Cr	₹10 Cr	₹11 Cr	₹7 Cr	₹1 Cr	₹10 Cr	₹9 Cr	₹5 Cr	₹1 Cr	₹11 Cr	₹5 Cr	₹5 Cr
₹4 L	₹5 L	₹5 L	₹5 L	₹5 L	₹4 L	₹6 L	₹6 L	₹7 L	₹5 L	₹5 L	₹3 L	₹2 L	₹2 L	₹2 L	₹2 L	₹2 L	₹30 L	₹3 L	₹7 L	₹9 L	₹37 L	₹4 L	₹5 L	₹5 L	₹7 L	₹5 L	₹5 L	₹5 L	₹3 L	₹0	₹4 L	₹2 L	₹3 L	₹10,000	₹4 L	₹6 L	₹7 L	₹7 L	₹10 L	₹6 L	₹2 L	₹3 L	₹4 L	₹10,000	₹4 L	₹11 L	₹16 L	₹17 L	₹33 L	₹39 L	₹45 L	₹45 L	₹73 L	₹57 L	₹54 L
₹6 Cr	₹21 Cr	₹26 Cr	₹19 Cr	₹11 Cr	₹21 Cr	₹26 Cr	₹16 Cr	₹6 Cr	₹20 Cr	₹24 Cr	₹9 Cr	₹9 Cr	₹16 Cr	₹15 Cr	₹17 Cr	₹5 Cr	₹20 Cr	₹28 Cr	₹26 Cr	₹16 Cr	₹14 Cr	₹28 Cr	₹31 Cr	₹9 Cr	₹11 Cr	₹13 Cr	₹12 Cr	-₹91 L	₹20 Cr	₹8 Cr	₹9 Cr	-₹2 Cr	₹10 Cr	₹10 Cr	₹14 Cr	-₹2 Cr	₹7 Cr	₹12 Cr	₹11 Cr	₹3 Cr	₹10 Cr	₹12 Cr	₹11 Cr	₹3 Cr	₹9 Cr	₹10 Cr	₹6 Cr	₹64 L	₹9 Cr	₹8 Cr	₹4 Cr	₹13 L	₹10 Cr	₹4 Cr	₹3 Cr
₹4 Cr	₹16 Cr	₹19 Cr	₹14 Cr	₹8 Cr	₹15 Cr	₹19 Cr	₹12 Cr	₹5 Cr	₹14 Cr	₹17 Cr	₹7 Cr	₹7 Cr	₹13 Cr	₹11 Cr	₹13 Cr	₹4 Cr	₹15 Cr	₹21 Cr	₹20 Cr	₹12 Cr	₹10 Cr	₹21 Cr	₹24 Cr	₹6 Cr	₹8 Cr	₹9 Cr	₹8 Cr	-₹70 L	₹14 Cr	₹5 Cr	₹6 Cr	-₹1 Cr	₹6 Cr	₹6 Cr	₹9 Cr	-₹1 Cr	₹3 Cr	₹9 Cr	₹7 Cr	₹2 Cr	₹5 Cr	₹9 Cr	₹7 Cr	₹2 Cr	₹6 Cr	₹7 Cr	₹4 Cr	₹73 L	₹6 Cr	₹5 Cr	₹3 Cr	₹16 L	₹7 Cr	₹2 Cr	₹2 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr
-₹60 L	₹42 L	-₹40 L	₹1 Cr	₹61 L	₹62 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹368 Cr	₹323 Cr	₹286 Cr	₹287 Cr	₹262 Cr	₹212 Cr	₹157 Cr	₹143 Cr	₹126 Cr	₹113 Cr	₹118 Cr	₹102 Cr	₹94 Cr	₹85 Cr	₹78 Cr	₹100 Cr	₹94 Cr	₹91 Cr	₹22 Cr	₹20 Cr
₹368 Cr	₹323 Cr	₹286 Cr	₹287 Cr	₹262 Cr	₹212 Cr	₹157 Cr	₹143 Cr	₹126 Cr	₹113 Cr	₹118 Cr	₹102 Cr	₹94 Cr	₹85 Cr	₹78 Cr	₹100 Cr	₹94 Cr	₹91 Cr	₹22 Cr	₹20 Cr
₹370 Cr	₹327 Cr	₹288 Cr	₹291 Cr	₹265 Cr	₹216 Cr	₹159 Cr	₹146 Cr	₹129 Cr	₹116 Cr	₹120 Cr	₹105 Cr	₹97 Cr	₹88 Cr	₹81 Cr	₹103 Cr	₹97 Cr	₹94 Cr	₹25 Cr	₹23 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹6 Cr	₹3 Cr	₹1 Cr	₹21 L	₹6 Cr	₹8 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹2 Cr	₹0
-₹5 Cr	-₹3 Cr	-₹3 Cr	-₹4 Cr	-₹4 Cr	-₹3 Cr	-₹4 Cr	-₹4 Cr	-₹4 Cr	-₹3 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹2 Cr
₹2 Cr	₹2 Cr	₹2 Cr	₹57 L	₹48 L	₹88 L	₹1 Cr	₹28 L	₹28 L	₹47 L	₹42 L	₹40 L	₹42 L	₹46 L	₹44 L	₹39 L	₹0	₹0	₹0	₹0
₹10 Cr	₹8 Cr	₹7 Cr	₹8 Cr	₹7 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹73 L	₹60 L	₹59 L	₹45 L	₹20 L	₹3 L	₹0	₹0	₹0	₹0
₹7 Cr	₹7 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹75 L	₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹9 Cr	₹8 Cr	₹4 Cr	₹3 Cr	₹12 Cr	₹10 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹71 Cr	₹69 Cr	₹56 Cr	₹47 Cr	₹60 Cr	₹41 Cr	₹31 Cr	₹30 Cr	₹26 Cr	₹25 Cr	₹9 Cr	₹7 Cr	₹7 Cr	₹9 Cr	₹8 Cr	₹6 Cr	₹12 Cr	₹7 Cr	₹6 Cr	₹6 Cr
₹40 Cr	₹12 Cr	₹10 Cr	₹10 Cr	₹13 Cr	₹8 Cr	₹6 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹14 Cr	₹10 Cr	₹7 Cr	₹9 Cr	₹7 Cr	₹10 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹2 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹2 Cr	₹0	₹0	₹6 Cr	₹13 Cr	₹14 Cr	₹22 Cr	₹0	₹0	₹0	₹0
₹16 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹59 L	₹2 Cr	₹6 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹1 Cr	₹97 L
₹126 Cr	₹85 Cr	₹70 Cr	₹63 Cr	₹77 Cr	₹52 Cr	₹39 Cr	₹36 Cr	₹32 Cr	₹32 Cr	₹25 Cr	₹23 Cr	₹24 Cr	₹35 Cr	₹34 Cr	₹43 Cr	₹18 Cr	₹14 Cr	₹10 Cr	₹8 Cr
₹504 Cr	₹418 Cr	₹364 Cr	₹358 Cr	₹346 Cr	₹271 Cr	₹201 Cr	₹183 Cr	₹162 Cr	₹149 Cr	₹149 Cr	₹130 Cr	₹124 Cr	₹127 Cr	₹124 Cr	₹153 Cr	₹119 Cr	₹111 Cr	₹47 Cr	₹41 Cr
₹7 Cr	₹16 Cr	₹16 Cr	₹10 Cr	₹10 Cr	₹13 Cr	₹13 Cr	₹8 Cr	₹11 Cr	₹12 Cr	₹14 Cr	₹17 Cr	₹15 Cr	₹13 Cr	₹11 Cr	₹5 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹3 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹2 Cr	₹0	₹0	₹6 Cr	₹13 Cr	₹22 Cr	₹27 Cr	₹1 Cr	₹21 L	₹8 Cr	₹8 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹89 Cr	₹82 Cr	₹76 Cr	₹74 Cr	₹48 Cr	₹39 Cr	₹39 Cr	₹35 Cr	₹33 Cr	₹30 Cr	₹39 Cr	₹26 Cr	₹32 Cr	₹32 Cr	₹31 Cr	₹40 Cr	₹24 Cr	₹25 Cr	₹34 Cr	₹25 Cr
₹38 Cr	₹32 Cr	₹26 Cr	₹25 Cr	₹19 Cr	₹16 Cr	₹13 Cr	₹9 Cr	₹6 Cr	₹3 Cr	₹16 Cr	₹13 Cr	₹18 Cr	₹15 Cr	₹12 Cr	₹10 Cr	₹9 Cr	₹9 Cr	₹14 Cr	₹13 Cr
₹51 Cr	₹49 Cr	₹50 Cr	₹49 Cr	₹28 Cr	₹23 Cr	₹26 Cr	₹26 Cr	₹28 Cr	₹27 Cr	₹22 Cr	₹13 Cr	₹15 Cr	₹17 Cr	₹19 Cr	₹30 Cr	₹16 Cr	₹16 Cr	₹19 Cr	₹13 Cr
₹105 Cr	₹16 Cr	₹2 Cr	₹1 Cr	₹16 Cr	₹41 L	₹0	₹0	₹0	₹68 L	₹72 L	₹4 Cr	₹97 L	₹54 L	₹35 L	₹44 L	₹7 Cr	₹2 Cr	₹3 Cr	₹3 Cr
₹5 L	₹5 L	₹4 L	₹2 L	₹5 Cr	₹12 Cr	₹18 Cr	₹16 Cr	₹8 Cr	₹7 Cr	₹10 Cr	₹14 Cr	₹14 Cr	₹30 Cr	₹31 Cr	₹52 Cr	₹46 Cr	₹43 L	₹43 L	₹11 L
₹5 L	₹5 L	₹4 L	₹2 L	₹5 Cr	₹12 Cr	₹18 Cr	₹16 Cr	₹8 Cr	₹7 Cr	₹10 Cr	₹14 Cr	₹14 Cr	₹30 Cr	₹31 Cr	₹52 Cr	₹46 Cr	₹43 L	₹43 L	₹11 L
₹9 Cr	₹20 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹5 Cr	₹21 Cr	₹21 Cr	₹20 Cr	₹19 Cr	₹22 Cr	₹4 Cr	₹0	₹0	₹0	₹0
₹46 Cr	₹42 Cr	₹12 Cr	₹43 Cr	₹17 Cr	₹8 Cr	₹28 Cr	₹28 L	₹4 Cr	₹0	₹0	₹0	₹2 Cr	₹2 Cr	₹2 Cr	₹0	₹0	₹0	₹0	₹0
₹212 Cr	₹128 Cr	₹68 Cr	₹98 Cr	₹72 Cr	₹48 Cr	₹75 Cr	₹44 Cr	₹41 Cr	₹41 Cr	₹54 Cr	₹52 Cr	₹51 Cr	₹69 Cr	₹74 Cr	₹86 Cr	₹68 Cr	₹19 Cr	₹22 Cr	₹15 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹3 Cr	₹0	₹5,000	₹5 Cr	₹8 Cr	₹6 Cr	₹0	₹2 Cr	₹0	₹2 Cr	₹0	₹0	₹0	₹0	₹4 Cr	₹17 Cr	₹0	₹0	₹0	₹0
₹37 Cr	₹27 Cr	₹29 Cr	₹29 Cr	₹26 Cr	₹17 Cr	₹24 Cr	₹15 Cr	₹10 Cr	₹10 Cr	₹8 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹9 Cr	₹9 Cr	₹7 Cr	₹5 Cr	₹9 Cr	₹9 Cr
₹61 Cr	₹56 Cr	₹48 Cr	₹33 Cr	₹38 Cr	₹18 Cr	₹26 Cr	₹33 Cr	₹28 Cr	₹29 Cr	₹26 Cr	₹26 Cr	₹24 Cr	₹27 Cr	₹13 Cr	₹12 Cr	₹10 Cr	₹13 Cr	₹8 Cr	₹5 Cr
₹33 Cr	₹83 Cr	₹27 Cr	₹70 Cr	₹88 Cr	₹139 Cr	₹36 Cr	₹81 Cr	₹73 Cr	₹31 Cr	₹48 Cr	₹38 Cr	₹35 Cr	₹15 Cr	₹15 Cr	₹20 Cr	₹24 Cr	₹68 Cr	₹3 Cr	₹8 Cr
₹2 Cr	₹1 Cr	₹81 L	₹6 Cr	₹6 Cr	₹7 Cr	₹4 Cr	₹3 Cr	₹7 Cr	₹1 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹80 L	₹2 L	₹8 L
₹155 Cr	₹123 Cr	₹191 Cr	₹116 Cr	₹109 Cr	₹35 Cr	₹36 Cr	₹6 Cr	₹3 Cr	₹35 Cr	₹9 Cr	₹4 Cr	₹6 Cr	₹7 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹6 Cr	₹5 Cr	₹4 Cr
₹292 Cr	₹291 Cr	₹296 Cr	₹260 Cr	₹275 Cr	₹223 Cr	₹126 Cr	₹140 Cr	₹121 Cr	₹108 Cr	₹95 Cr	₹79 Cr	₹73 Cr	₹58 Cr	₹50 Cr	₹67 Cr	₹51 Cr	₹92 Cr	₹25 Cr	₹26 Cr
₹165 Cr	₹206 Cr	₹226 Cr	₹197 Cr	₹197 Cr	₹171 Cr	₹87 Cr	₹104 Cr	₹89 Cr	₹76 Cr	₹69 Cr	₹56 Cr	₹49 Cr	₹22 Cr	₹16 Cr	₹24 Cr	₹33 Cr	₹79 Cr	₹16 Cr	₹18 Cr
₹504 Cr	₹418 Cr	₹364 Cr	₹358 Cr	₹346 Cr	₹271 Cr	₹201 Cr	₹183 Cr	₹162 Cr	₹149 Cr	₹149 Cr	₹130 Cr	₹124 Cr	₹127 Cr	₹124 Cr	₹153 Cr	₹119 Cr	₹111 Cr	₹47 Cr	₹41 Cr
₹128	₹113	₹100	₹99	₹90	₹74	₹55	₹50	₹88	₹79	₹82	₹72	₹66	₹60	₹277	₹340	₹321	₹302	₹80	₹72
₹128	₹113	₹100	₹99	₹90	₹74	₹55	₹50	₹44	₹40	₹41	₹36	₹33	₹30	₹28	₹34	₹32	₹30	₹8	₹7

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
₹78 Cr	₹69 Cr	₹62 Cr	₹54 Cr	₹91 Cr	₹82 Cr	₹34 Cr	₹35 Cr	₹33 Cr	₹34 Cr	₹35 Cr	₹26 Cr	₹21 Cr	₹18 Cr	₹19 Cr	₹16 Cr	₹19 Cr	₹19 Cr	₹10 Cr	₹14 Cr
-₹11 Cr	-₹9 Cr	-₹7 Cr	-₹8 Cr	-₹10 Cr	-₹3 Cr	-₹83 L	-₹3 Cr	-₹4 Cr	-₹41 L	-₹2 Cr	-₹83 L	₹3 Cr	₹3 Cr	₹2 Cr	-₹1 Cr	-₹2 Cr	-₹5 Cr	₹2 Cr	₹1 Cr
-₹12 Cr	₹9 Cr	-₹10 Cr	-₹10 Cr	-₹4 Cr	₹31 Cr	-₹4 Cr	-₹81 L	₹47 L	-₹11 Cr	₹71 L	₹3 Cr	₹70 L	-₹6 Cr	-₹3 Cr	-₹4 Cr	₹3 Cr	-₹1 Cr	-₹5 Cr	₹2 Cr
₹55 Cr	₹69 Cr	₹44 Cr	₹36 Cr	₹76 Cr	₹110 Cr	₹29 Cr	₹31 Cr	₹30 Cr	₹22 Cr	₹33 Cr	₹28 Cr	₹25 Cr	₹14 Cr	₹19 Cr	₹10 Cr	₹20 Cr	₹13 Cr	₹8 Cr	₹18 Cr
₹36 Cr	₹51 Cr	₹28 Cr	₹20 Cr	₹52 Cr	₹91 Cr	₹18 Cr	₹21 Cr	₹19 Cr	₹8 Cr	₹21 Cr	₹19 Cr	₹18 Cr	₹8 Cr	₹13 Cr	₹6 Cr	₹12 Cr	₹7 Cr	₹6 Cr	₹11 Cr
-₹21 Cr	-₹31 Cr	₹19 Cr	-₹2 Cr	-₹36 Cr	-₹88 Cr	-₹14 Cr	-₹11 Cr	-₹8 Cr	-₹29 L	₹1 Cr	-₹5 Cr	₹16 Cr	₹11 Cr	₹4 Cr	-₹30 Cr	-₹47 Cr	₹88 Cr	-₹9 Cr	-₹4 Cr
-₹14 Cr	-₹13 Cr	-₹48 Cr	-₹15 Cr	-₹17 Cr	-₹7 Cr	-₹12 Cr	-₹7 Cr	-₹9 Cr	-₹5 Cr	-₹11 Cr	-₹12 Cr	-₹14 Cr	-₹17 Cr	-₹27 Cr	₹20 Cr	-₹8 Cr	-₹30 Cr	-₹2 Cr	-₹1 Cr
₹1 Cr	₹6 Cr	-₹1 Cr	₹3 Cr	-₹72 L	-₹4 Cr	-₹7 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹12 Cr	₹2 Cr	₹20 Cr	₹2 Cr	-₹9 Cr	-₹4 Cr	-₹43 Cr	₹65 Cr	-₹5 Cr	₹6 Cr
₹10 Cr	₹4 Cr	₹5 Cr	₹2 Cr	₹3 Cr	₹7 Cr	₹15 Cr	₹11 Cr	₹10 Cr	₹22 Cr	₹31 Cr	₹29 Cr	₹9 Cr	₹7 Cr	₹24 Cr	₹24 Cr	₹68 Cr	₹3 Cr	₹8 Cr	₹2 Cr
₹0	₹0	₹0	₹0	-₹2,000	-₹9,000	-₹10,000	-₹7,000	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	-₹5 L
₹11 Cr	₹10 Cr	₹4 Cr	₹5 Cr	₹2 Cr	₹3 Cr	₹7 Cr	₹15 Cr	₹11 Cr	₹25 Cr	₹42 Cr	₹31 Cr	₹29 Cr	₹9 Cr	₹15 Cr	₹20 Cr	₹24 Cr	₹68 Cr	₹3 Cr	₹8 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Amrutanjan Health Care Share Price

496.05+2.25 (+0.46%)

-35.16% past 1 Year

Shareholding summary

Promoters

46.52%

FII

2.44%

DII

6.47%

5.82%

Others

38.75%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
46.52%	46.52%	46.52%	46.52%	46.52%	46.52%
2.44%	2.17%	2.27%	2.38%	2.41%	2.30%
6.47%	5.64%	5.45%	5.35%	5.15%	3.86%
5.82%	7.02%	7.55%	7.55%	7.55%	7.55%
38.75%	38.65%	38.21%	38.20%	38.37%	39.77%

Bulk & block deals

Name

Pari Washington India Master Fund, Ltd.

Dsp Mutual Fund

Envision India Fund

Sundaram Mutual Fund

Nageswaramma Private Trust

Icici Prudential Mutual Fund

Nageswaramma Private Trust

Graviton Research Capital Llp

N.k.securities

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
20 Aug 2026	Purchase	29.17 Cr	₹500	5.83 L	Bulk	2.018225	BSE
20 Aug 2026	Sell	25 Cr	₹500.01	5 L	Bulk	1.729469	BSE
20 Aug 2026	Sell	11.15 Cr	₹523.58	2.13 L	Bulk	0.736754	NSE
13 Jan 2025	Sell	14.95 Cr	₹700	2.13 L	Bulk	0.738483	NSE
27 Sep 2024	Sell	25.36 Cr	₹745.29	3.40 L	Bulk	1.17699	BSE
26 Sep 2024	Purchase	49.40 Cr	₹760	6.50 L	Bulk	2.24831	NSE
26 Sep 2024	Sell	63.29 Cr	₹760.08	8.33 L	Bulk	2.880345	NSE
30 Jun 2023	Purchase	14.12 Cr	₹737.21	1.92 L	Bulk	0.662522	NSE
30 Jun 2023	Sell	14.13 Cr	₹737.86	1.92 L	Bulk	0.662522	NSE
10 Jun 2020	Purchase	14.29 Cr	₹384.97	3.71 L	Bulk	1.284086	NSE

Insider trading & SAST

Client name

Dsp Trustee Pvt Ltd & Others

S Jeyakanth

Nageswaramma Private Trust

Nageswaramma Pvt Trust

Nageswaramma Private Trust

Aravind Prasad Venketasesha Sivalenka

Goodhealth Holdings Pvt Ltd

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
24 Aug 2026	Other	Disposal	0.73	2.82	0	—	2.11 L	31 Jul 2026	Market	8,16,220	SAST	29(2)	—
29 May 2025	Designated Person	Disposal	0.004843	0	0	—	1.40 K	21 May 2025 - 28 May 2025	Market Sale	156	Insider Trading	—	Equity Shares
18 Oct 2024	Promoter	Disposal	1.18	4.74	0	—	3.40 L	27 Sep 2024	Market	13,71,530	SAST	29(2)	—
03 Oct 2024	Promoter	Disposal	1.17699	4.74	24.73 Cr	₹726.66	3.40 L	27 Sep 2024	Market Sale	13,71,530	Insider Trading	—	Equity Shares
01 Oct 2024	Promoter	Disposal	2.88	5.92	0	—	8.33 L	26 Sep 2024	Market	17,11,805	SAST	29(2)	—
30 Sep 2024	Promoter	Disposal	2.880345	5.92	61.71 Cr	₹741.08	8.33 L	26 Sep 2024	Market Sale	17,11,805	Insider Trading	—	Equity Shares
15 Jun 2024	Promoter	Acquisition	0.13	8.81	0	—	36.53 K	12 Jun 2024	Transmission	25,44,530	SAST	29(2)	—
08 May 2024	Promoter	Acquisition	0.01	0.01	0	—	4.42 K	02 May 2024	Transmission	4,420	SAST	29(1)	—
08 May 2024	Promoter	Acquisition	0.01	0.01	0	—	4.42 K	02 May 2024	Transmission	4,420	SAST	29(2)	—
07 Mar 2024	Promoter	Acquisition	20.15	50.59	0	—	58.26 L	29 Feb 2024	Transfer	1,46,25,610	SAST	29(1)	—

Amrutanjan Health Care Share Price

496.05+2.25 (+0.46%)

-35.16% past 1 Year

Amrutanjan Health Care Ltd is engaged in the manufacture of a wide range of ayurvedic and allopathic products. The company's products are available in the Gulf African South East and

Corporate Actions

Date

Type

Details

2026-09-11

Dividend

2.9

2026-02-06

Dividend

1.0

2025-11-18

Dividend

1.0

2025-09-16

Dividend

2.6

2025-02-18

Dividend

1.0

2024-11-22

Dividend

1.0

2024-09-13

Dividend

2.6

2024-02-20

Dividend

1.0

2023-11-23

Dividend

1.0

2023-09-14

Dividend

2.6

2023-02-24

Dividend

1.0

2022-11-14

Dividend

1.0

2022-09-14

Dividend

2.6

2021-11-16

Dividend

1.0

2021-09-15

Dividend

2.6

2021-02-17

Dividend

0.8

2020-11-19

Dividend

0.8

2020-02-18

Dividend

1.55

2019-11-15

Dividend

0.55

2019-09-17

Dividend

1.05

2019-02-20

Dividend

0.55

2018-11-12

Dividend

0.55

2018-09-07

Dividend

0.85

2018-04-13

Split

2:1

2018-02-22

Dividend

1.1

2017-11-16

Dividend

1.1

2017-09-13

Dividend

1.65

2017-02-16

Dividend

1.1

2016-11-17

Dividend

1.1

2016-03-18

Dividend

2.65

2016-02-17

Dividend

1.2

2015-09-10

Dividend

2.4

2015-02-13

Dividend

1.1

2014-09-17

Dividend

2.2

2014-02-17

Dividend

1.0

2013-08-02

Dividend

2.0

2013-02-21

Dividend

1.0

2012-10-25

Split

10:2

2012-09-20

Dividend

10.0

2012-02-23

Dividend

5.0

2011-09-12

Dividend

10.0

2011-02-21

Dividend

5.0

2010-08-13

Dividend

10.0

Company details

Registered office

New 103 (Old 42-45) Luz Church Road Mylapore Chennai Tamil Nadu PIN: 600004 Tel No: 044-24994164 / 24994146 / 24994465 / 24994366 / 24 Fax No: 044-24994585 Email: [email protected] Internet: www.amrutanjan.com

Registrars

Subramanian Buildings No 1 , Club House Road,,Chennai Subramanian Buildings No 1 Club House Road NULL PIN: Tel No: 044-28460390/28460394 Fax No: 044-28460129 Email: NULL

Management

Gagan Preet Singh, General Manager - Legal, Company Secretary & Compliance Officer

S Sambhu Prasad, Chairman & Managing Director

S Muralidharan, Non Executive Independent Director

Meenalochani Raghunathan, Non Executive Independent Director

V Nagaraj, Non Executive Independent Director

Ramaswami Krishnan, Non Executive Independent Director

Ramaa Prabhakar Arikirevula, Non Independent & Non Executive Director

Details

Amrutanjan Health Care Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Amrutanjan Health Care Share Price

Amrutanjan Health Care Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Amrutanjan Health Care Share Price

Amrutanjan Health Care Share Price

Oscillators

Moving averages

Amrutanjan Health Care Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Amrutanjan Health Care Share Price

Corporate Actions

Company details

Amrutanjan Health Care Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Amrutanjan Health Care Share Price

News

Amrutanjan Healthcare sees Rs 46.51 crore BSE block trade at Rs 500 per share

Amrutanjan Health Care posts lower Q1 EBITDA and margin year on year

Amrutanjan Health Care reports Q1 revenue rise to Rs 100.00 crores

Amrutanjan Health Care reports lower first quarter net profit year on year

Amrutanjan commissions new Telangana sanitary napkin plant with Rs 150 crore capex

Amrutanjan Health Care Adds 44,000 New Chemists, Targets 100,000 by September FY27

Amrutanjan Healthcar - Quaterly Results

Amrutanjan Healthcar reports Profit after tax of 16.19 Crores, in the March 2026 quarter

Amrutanjan Health Care Reports Strong Q4 EBITDA Growth to Rs 25.50 Crores, Margin at 17.05%

Amrutanjan Health Care Q4 FY25 Net Profit Rises 6% YoY to Rs 16.10 Crores, Revenue Up 11% to Rs 150 Crores

Amrutanjan Health Care informs about product launch

Amrutanjan Healthcar - Quaterly Results

Amrutanjan Health Care Q3 EBITDA Rises 7.7% YoY to Rs 25.20 Crores, Margin Contracts to 17.85%.

Amrutanjan Health Care Q3 Net Profit Up Slightly to Rs 19.50 Crores, Revenue Rises to Rs 140 Crores YoY.

Amrutanjan Healthcar reports Profit after tax of 19.45 Crores, in the December 2025 quarter

Amrutanjan Health Care informs about certificate

Amrutanjan Health Care informs about closure of trading window

Amrutanjan Health Care Q2 profit rises; revenue, EBITDA and margins show YoY growth.

Amrutanjan Healthcar reports Profit after tax of 13.96 Crores, in the September 2025 quarter

Amrutanjan Health Care informs about board meeting

Amrutanjan Health Care Ltd Share Price Today

Amrutanjan Health Care Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator